Kenneth Wester
Overview
Explore the profile of Kenneth Wester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
4628
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carlsson J, Wester K, de la Torre M, Malmstrom P, Gardmark T
Radiol Oncol
. 2015 Mar;
49(1):50-8.
PMID: 25810701
Background: There is limited effect of tyrosine kinase inhibitors or "naked" antibodies binding EGFR or HER2 for therapy of metastasized urinary bladder cancer and these methods are therefore not routinely...
2.
Algenas C, Agaton C, Fagerberg L, Asplund A, Bjorling L, Bjorling E, et al.
Biotechnol J
. 2014 Jan;
9(3):435-45.
PMID: 24403002
An important concern for the use of antibodies in various applications, such as western blot (WB) or immunohistochemistry (IHC), is specificity. This calls for systematic validations using well-designed conditions. Here,...
3.
Linden M, Segersten U, Runeson M, Wester K, Busch C, Pettersson U, et al.
BJU Int
. 2013 Mar;
112(3):407-15.
PMID: 23470167
Unlabelled: WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: The current basis for diagnosis and prognosis in urinary bladder cancer is based on the pathologists' assessment of...
4.
Gedda L, Bjorkelund H, Lebel L, Asplund A, Dubois L, Wester K, et al.
Appl Immunohistochem Mol Morphol
. 2013 Mar;
21(6):497-505.
PMID: 23455178
Immunohistochemical study (IHC) is a critical tool in the clinical diagnosis of breast cancer. One common assessment is the expression level of the HER2 receptor in breast cancer tissue samples...
5.
Fagelskiold A, Kannisto K, Bostrom A, Hadrovic B, Farre C, Eweida M, et al.
Islets
. 2012 Jan;
4(1):56-63.
PMID: 22274646
We have studied whether functional TRPV1 channels exist in the INS-1E cells, a cell type used as a model for β-cells, and in primary β-cells from rat and human. The...
6.
Malmberg J, Sandstrom M, Wester K, Tolmachev V, Orlova A
Nucl Med Biol
. 2011 Dec;
38(8):1093-102.
PMID: 22137850
Introduction: Human epidermal growth factor receptor type 2 (HER2) overexpression supports proliferation of androgen-independent prostate cancer (PC). Radionuclide molecular imaging of HER2 expression in disseminated PC would aid in the...
7.
Linden M, Lind S, Mayrhofer C, Segersten U, Wester K, Lyutvinskiy Y, et al.
Proteomics
. 2011 Nov;
12(1):135-44.
PMID: 22065568
Nonmuscle invasive tumors of the bladder often recur and thereby bladder cancer patients need regular re-examinations which are invasive, unpleasant, and expensive. A noninvasive and less expensive method, e.g. a...
8.
Magnusson K, de Wit M, Brennan D, Johnson L, McGee S, Lundberg E, et al.
Am J Surg Pathol
. 2011 Jun;
35(7):937-48.
PMID: 21677534
The special AT-rich sequence-binding protein 2 (SATB2), a nuclear matrix-associated transcription factor and epigenetic regulator, was identified as a tissue type-specific protein when screening protein expression patterns in human normal...
9.
Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, et al.
Nat Biotechnol
. 2010 Dec;
28(12):1248-50.
PMID: 21139605
No abstract available.
10.
Jaraj S, Augsten M, Haggarth L, Wester K, Ponten F, Ostman A, et al.
Scand J Urol Nephrol
. 2010 Nov;
45(1):39-45.
PMID: 21091088
Objective: Tissue-specific markers are useful for identification of tumour type in advanced cancers of unknown origin. This study investigated the expression of glutamate decarboxylase 1 (GAD1) in prostate and control...